Home
NMRA
NMRA News

Latest Neumora Therapeutics Inc. (NMRA) News on April 2, 2025

MT Newswires

23 days ago

William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform

JNJ Halts Development of Depression Drug Over Efficacy Concerns

Zacks

a month ago

JNJ Halts Development of Depression Drug Over Efficacy Concerns

J&J drops Phase III MDD programme due to lack of efficacy

Clinical Trials Arena

a month ago

J&J drops Phase III MDD programme due to lack of efficacy

MT Newswires

a month ago

Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6

J&J scraps depression testing for potential blockbuster drug

BioPharma Dive

a month ago

J&J scraps depression testing for potential blockbuster drug

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

GlobeNewswire

a month ago

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

BioPharma Dive

a month ago

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

MT Newswires

a month ago

Stifel Adjusts Price Target on Neumora Therapeutics to $6 From $26, Maintains Buy Rating

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

a month ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MT Newswires

a month ago

Mizuho Securities Adjusts Neumora Therapeutics Price Target to $4 From $20, Maintains Outperform Rating

3 US Penny Stocks With Market Caps Below $400M

Simply Wall St.

a month ago

3 US Penny Stocks With Market Caps Below $400M

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

BioPharma Dive

2 months ago

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

MT Newswires

2 months ago

Neumora Therapeutics Names Paul Berns as CEO, Michael Milligan as CFO

Neumora Therapeutics Announces Leadership Transition

GlobeNewswire

2 months ago

Neumora Therapeutics Announces Leadership Transition

3 US Penny Stocks With Market Caps Over $30M To Watch

Simply Wall St.

3 months ago

3 US Penny Stocks With Market Caps Over $30M To Watch

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks

3 months ago

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Neumora shares look oversold after 80% drop, says Mizuho

TipRanks

3 months ago

Neumora shares look oversold after 80% drop, says Mizuho

MT Newswires

3 months ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

3 months ago

Sector Update: Health Care Stocks Higher Friday Afternoon

MT Newswires

3 months ago

Neumora Has 2 More Chances With Navacaprant After Readout Miss, Mizuho Says

Neumora Stock Hits Record Low on Depression Drug Study Failure

Zacks

3 months ago

Neumora Stock Hits Record Low on Depression Drug Study Failure

Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression

TipRanks

3 months ago

Neumora Therapeutics’ navacaprant did not meet primary endpoint in depression

Results are in for a new depression drug trial, and they're cratering this stock

Quartz

3 months ago

Results are in for a new depression drug trial, and they're cratering this stock

MT Newswires

3 months ago

Sector Update: Health Care Stocks Ease Thursday Afternoon

MT Newswires

3 months ago

Top Midday Decliners

Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial

Insider Monkey

3 months ago

Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial

Neumora shares sink following Phase III flop in MDD

Pharmaceutical Technology

3 months ago

Neumora shares sink following Phase III flop in MDD

MT Newswires

3 months ago

--RBC Downgrades Neumora Therapeutics to Sector Perform From Outperform, Price Target is $4

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

Investor's Business Daily

3 months ago

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

MT Newswires

3 months ago

Sector Update: Health Care

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

Benzinga

3 months ago

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

Neumora Plunges After Depression Drug Fails in Final-Stage Study

Bloomberg

3 months ago

Neumora Plunges After Depression Drug Fails in Final-Stage Study

MT Newswires

3 months ago

Neumora Therapeutics' Phase 3 Trial of Navacaprant in Major Depressive Disorder Fails to Meet Primary Endpoint; Shares Plunge

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

GlobeNewswire

3 months ago

Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode

Insider Monkey

4 months ago

Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode

MT Newswires

5 months ago

Neumora Therapeutics Q3 Loss Narrows

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in November

GlobeNewswire

5 months ago

Neumora Therapeutics to Participate in Upcoming Conferences in November

MT Newswires

5 months ago

JPMorgan Downgrades Neumora Therapeutics to Neutral, $15 Price Target

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

GlobeNewswire

5 months ago

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

MT Newswires

5 months ago

Neumora Therapeutics Insider Sold Shares Worth $370,962, According to a Recent SEC Filing

Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

6 months ago

Neumora Therapeutics (NASDAQ:NMRA) Is In A Good Position To Deliver On Growth Plans

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

GlobeNewswire

8 months ago

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

MT Newswires

8 months ago

Neumora Therapeutics Shares Decline After Q2 Results

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

MT Newswires

8 months ago

Needham Initiates Neumora Therapeutics With Buy Rating, $23 Price Target

MT Newswires

9 months ago

Mizuho Securities Initiates Neumora Therapeutics at Outperform With $20 Price Target

10 clinical trials to watch in the second half of 2024

BioPharma Dive

9 months ago

10 clinical trials to watch in the second half of 2024

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation

GlobeNewswire

9 months ago

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation

This Neumora Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.

10 months ago

This Neumora Therapeutics Insider Increased Their Holding In The Last Year

MT Newswires

a year ago

Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

GlobeNewswire

a year ago

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

MT Newswires

a year ago

Neumora Therapeutics Shares Fall as Q1 Loss Narrows

Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Neumora Therapeutics to Participate in Upcoming Conferences in May

GlobeNewswire

a year ago

Neumora Therapeutics to Participate in Upcoming Conferences in May

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Simply Wall St.

a year ago

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success

Zacks

a year ago

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug

Zacks

a year ago

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Investor's Business Daily

a year ago

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?

Benzinga

a year ago

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?

Neumora’s schizophrenia drug hit with clinical hold

BioPharma Dive

a year ago

Neumora’s schizophrenia drug hit with clinical hold

Reuters

a year ago

U.S. FDA places clinical hold on Neumora's schizophrenia drug study

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

GlobeNewswire

a year ago

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop

Simply Wall St.

a year ago

institutional investors of Neumora Therapeutics, Inc. (NASDAQ:NMRA) must be disappointed after last week's 20% drop

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days

GlobeNewswire

a year ago

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Google releases GenAI tools for music creation

TechCrunch

a year ago

Google releases GenAI tools for music creation

Encore Wire (WIRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

a year ago

Encore Wire (WIRE) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Teladoc (TDOC) Stock Moves -1.57%: What You Should Know

Zacks

a year ago

Teladoc (TDOC) Stock Moves -1.57%: What You Should Know

Reuters

a year ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today

Motley Fool

a year ago

A Massive Problem With Apple Stock Today

ITRI vs. AME: Which Stock Is the Better Value Option?

Zacks

a year ago

ITRI vs. AME: Which Stock Is the Better Value Option?

Jim Cramer is Bullish on These 10 Stocks

Insider Monkey

a year ago

Jim Cramer is Bullish on These 10 Stocks

Atkore Inc. Initiates Quarterly Dividend

Business Wire

a year ago

Atkore Inc. Initiates Quarterly Dividend

Business Wire

a year ago

Dillard’s, Citi and Mastercard Announce New Credit Card Agreements

25 Best Dividend Growth Stocks to Buy and Hold in 2024

Insider Monkey

a year ago

25 Best Dividend Growth Stocks to Buy and Hold in 2024

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.

Motley Fool

a year ago

The S&P 500 Just Hit an All-Time High. Here's 1 Artificial Intelligence (AI) Stock to Buy and Hold Hand Over Fist.

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

First Hawaiian, Inc. (NASDAQ:FHB) Q4 2023 Earnings Call Transcript

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

Zacks

a year ago

Innovative Industrial Properties (IIPR) Gains As Market Dips: What You Should Know

INTERCORP FINANCIAL SERVICES, INC. TO HOST FOURTH QUARTER 2023 EARNINGS CONFERENCE CALL & VIDEO WEBCAST PRESENTATION

PR Newswire

a year ago

INTERCORP FINANCIAL SERVICES, INC. TO HOST FOURTH QUARTER 2023 EARNINGS CONFERENCE CALL & VIDEO WEBCAST PRESENTATION

Thomson Reuters StreetEvents

a year ago

Q4 2023 Cathay General Bancorp Earnings Call

7 Battery Stocks to Turn $100,000 Into $1 Million: January 2024

InvestorPlace

a year ago

7 Battery Stocks to Turn $100,000 Into $1 Million: January 2024

GuruFocus.com

a year ago

Cathay General Bancorp (CATY) Reports Full Year and Q4 2023 Earnings

Associated Press Finance

a year ago

Cathay: Q4 Earnings Snapshot

Cathay General Bancorp Announces Fourth Quarter and Full Year 2023 Results

Business Wire

a year ago

Cathay General Bancorp Announces Fourth Quarter and Full Year 2023 Results

5 Top Stocks to Gain as Consumer Confidence Buoys Up

Zacks

a year ago

5 Top Stocks to Gain as Consumer Confidence Buoys Up

Business Wire

a year ago

Dillard’s to Donate more than $245,000 to local RMHC Chapters through sale of Southern Living Christmas Cookbook

Associated Press Finance

a year ago

United Community Banks: Q4 Earnings Snapshot

United Community Banks, Inc. Reports Fourth Quarter Results

GlobeNewswire

a year ago

United Community Banks, Inc. Reports Fourth Quarter Results

Unlocking Q4 Potential of United Community Banks (UCBI): Exploring Wall Street Estimates for Key Metrics

Zacks

a year ago

Unlocking Q4 Potential of United Community Banks (UCBI): Exploring Wall Street Estimates for Key Metrics

Should You Buy United Community Banks (UCBI) Ahead of Earnings?

Zacks

a year ago

Should You Buy United Community Banks (UCBI) Ahead of Earnings?

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

GlobeNewswire

a year ago

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

The Zacks Analyst Blog Highlights Carrols Restaurant, Shake Shack, Arcos Dorados, Chipotle Mexican Grill and Darden Restaurants

Zacks

a year ago

The Zacks Analyst Blog Highlights Carrols Restaurant, Shake Shack, Arcos Dorados, Chipotle Mexican Grill and Darden Restaurants

Department Store Stocks Q3 Highlights: Nordstrom (NYSE:JWN)

StockStory

a year ago

Department Store Stocks Q3 Highlights: Nordstrom (NYSE:JWN)

BancFirst (BANF) Q4 Earnings and Revenues Top Estimates

Zacks

a year ago

BancFirst (BANF) Q4 Earnings and Revenues Top Estimates

MATSON ANNOUNCES PRELIMINARY 4Q23 RESULTS, PROVIDES BUSINESS UPDATE AND ANNOUNCES 4Q23 EARNINGS CALL DATE

PR Newswire

a year ago

MATSON ANNOUNCES PRELIMINARY 4Q23 RESULTS, PROVIDES BUSINESS UPDATE AND ANNOUNCES 4Q23 EARNINGS CALL DATE

Insider Sell: Ciena Corp President and CEO Gary Smith Sells 4,166 Shares

GuruFocus.com

a year ago

Insider Sell: Ciena Corp President and CEO Gary Smith Sells 4,166 Shares

Columbia Banking (COLB) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

a year ago

Columbia Banking (COLB) Expected to Beat Earnings Estimates: Should You Buy?

LP Building Solutions Announces Dates for Fourth Quarter and Year-End 2023 Earnings Conference Call and Investor Day at the International Builders’ Show®

Business Wire

a year ago

LP Building Solutions Announces Dates for Fourth Quarter and Year-End 2023 Earnings Conference Call and Investor Day at the International Builders’ Show®

Pan American Silver Announces Preliminary 2023 Production Results and Guidance for 2024

Business Wire

a year ago

Pan American Silver Announces Preliminary 2023 Production Results and Guidance for 2024

Share on Social Networks: